![]() ![]() For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.Ībbott - A Leader in Rapid Point-of-Care Diagnostics.Patients with type 2 diabetes (T2DM) present an increased risk of cardiovascular (CV) disease and excess CV-related mortality. Check with your local representative for availability in specific markets. Not all products are available in all regions. GDPR Statement | Declaration for California Compliance Law. ![]() Any person depicted in such photographs is a model. Photos displayed are for illustrative purposes only. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. This website is governed by applicable U.S. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Hospital Healthcare Europe, special supplement, 2015. The economic benefits of point-of-care testing. What Do Consumers Want from Primary Care? 10 Insights from the Primary Care Consumer Choice Survey, The Advisory Board Company, Marketing and Planning Leadership Council 2014.Effect of troponin I Point-of-Care testing on emergency department throughput measures and staff satisfaction. Koehler J, Flarity K, Hertner G, et al.Crocker J, et al, Implementation of Point-of-Care Testing in an Ambulatory Practice of an Academic Medical Center, Am J Clin Pathol, November 2014 142:640-646.Press Ganey 2009 Medical Practice Pulse Report (Represents the experiences of 2,373,288 patients treated at 10,214 sites nationwide).Data on file Abbott Point of Care Inc., Instructions for use, test comparison tables.Point-of-care-testing-for-human-chorionic-gonadotophin hcg. National Institute for Health Research.Briguori, C., Tavano, D., Colombo, A., “Contrast Agent-Associated Nephrotoxicity.” Progress in Cardiovascular Diseases, 2003.45(6): 493-503.https: ///cgi/viewcontent.cgi?article=1004&context=pacbposters Evans, Susanne Gallo, Joseph Leo, Barbara M. Activated Clotting Time (ACT): Comparison of the Hemochron Signature Elite and the Abbott i-STAT.Detecting, managing and monitoring haemostasis: viscoelastometric point of care testing. National Institute for Health and Care Excellence.Canadian Institute for Health Information, August 2016 Cost Analysis on Intensive Care Unit Costs Based on the Length of Stay. ![]() The i-STAT System offers quick results for most tests needed for surgery on a single, portable platform, while providing all tests needed in the Cath Lab with better reproducibility than some benchtop systems. In the Cath Lab, it’s important that both activated clotting time (ACT) and blood gas results are readily available. Analysis via bench-tops (where the operating room assistant must leave the room to perform tests) can be costly, as well as potentially increase staffing requirements and impact patient care. The variables can potentially increase staffing requirements and impact patient care. Costly challenges, such as surgical cancellations, can add up, while the sharing of benchtop blood-gas-analysis systems among operating rooms can cause delays due to the nurse having to leave the room, the system already being in use or frequent calibration requirements. Because of the delicate nature of surgery, real-time test results are often critical, yet results from the central lab can take 60 minutes 5 or more. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |